NCT00839904 Physical Activity and Health of Children With Cancer in Remission Status COMPLETED Phase NA
NCT00838201 Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer Status COMPLETED Phase PHASE3
NCT00836160 Comparing Efficacy Between Anti-microtubule and Non-anti-microtubule as 3th Therapy After 2nd Line EGFR-TKI Therapy Status COMPLETED Phase N/A
NCT00833040 A Study for the Evaluation of the Safety, Tolerability, and Efficacy of ARX-F02 (Sufentanil NanoTab) Compared to Placebo in the Treatment of Cancer Breakthrough Pain Status COMPLETED Phase PHASE2
NCT00832871 Compassionate Use of Mifepristone in Brain/Nervous System and Other Cancers Status TERMINATED Phase NA
NCT00832325 Adolescent and Young Adult Cancer Survivors: Identity Development Status ACTIVE_NOT_RECRUITING Phase N/A
NCT00827801 M. D. Anderson Symptom Inventory - Heart Failure (MDASI-HF) Symptom Management Program Status COMPLETED Phase N/A
NCT00824278 The Use of a Distress Thermometer in a Pediatric Research Setting: An Exploratory Pilot Study Status COMPLETED Phase N/A
NCT00823394 African American Cancer Prevention Project: Establishing a Cohort to Investigate Health Disparities Status UNKNOWN Phase N/A
NCT00822822 Evaluation of Patient Functionality and Utility of Web-Based Personal Health History and Risk Assess Status COMPLETED Phase N/A
NCT00822809 CASIMAS: Catumaxomab Safety Phase IIIb Study With Intraperitoneal Infusion in Patients With Malignant Ascites Due to Epithelial Cancers Status COMPLETED Phase PHASE3
NCT00817752 Ashwagandha: Effects on Stress, Inflammation and Immune Cell Activation Status COMPLETED Phase PHASE1
NCT00816400 A Dose Escalation, Dose Expansion Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-575, in Subjects With Advanced Tumors. Status COMPLETED Phase PHASE1
NCT00816361 A Dose-escalation Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-573 in Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00813592 Phase II Study of SOM230 in Patients With Recurrent or Progressive Meningioma Status TERMINATED Phase PHASE2
NCT00813384 A Phase 1 Study of AMG 208 in Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00807859 Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer Status COMPLETED Phase PHASE1